• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Quantum Leap Energy LLC Completes the Acquisition of One 30 Seven Inc. Assets to Advance Solutions for the Processing of Water-Soluble Nuclear Waste

    10/23/25 8:00:00 AM ET
    $ASPI
    Major Chemicals
    Industrials
    Get the next $ASPI alert in real time by email
    • Quantum Leap Energy LLC plans to utilize technology acquired from One 30 Seven to develop Creber Units to process water-soluble nuclear waste by accelerating beta decay of radioactive waste, such as Cesium-137 and Strontium-90.



    • There are currently 390,000 Metric Tons of radioactive waste globally, of which over 90,000 Metric Tons sit in the United States. [1]



    • The total estimated liability for the Department of Energy failing to dispose of commercial spent fuel was estimated at $44.5 billion in 2024, not including funds already paid out. [2]



    • After this acquisition, Quantum Leap Energy intends to operate in several critical segments of the nuclear fuel cycle, including Conversion, Deconversion, Enrichment, and Nuclear Waste processing.

    WASHINGTON, Oct. 23, 2025 (GLOBE NEWSWIRE) -- ASP Isotopes, Inc. NASDAQ: ASPI ("ASP Isotopes" or the "Company") today announced that its subsidiary, Quantum Leap Energy LLC ("Quantum Leap Energy" or "QLE"), an advanced nuclear fuels company dedicated to the development of technology and processes across critical segments of the nuclear fuel cycle, has completed the purchase of certain assets from One 30 Seven Inc., a Canadian company engaged in the business of researching and developing decontamination solutions for water-soluble nuclear waste, particularly radioactive waste from radioactive materials from nuclear power plants, radiopharmaceuticals, and military sources.

    Quantum Leap Energy acquired substantially all of the assets of One 30 Seven, including an international patent application and its related rights for a system and method for treating radioactively contaminated water. Quantum Leap Energy also engaged B-Con Engineering Inc., a company affiliated with One 30 Seven, to develop water-soluble nuclear waste decontamination solutions based on the acquired patent that process water-soluble nuclear waste by accelerating beta decay of radioactive waste, such as Cesium-137 and Strontium-90. The goal of the acquisition of One30Seven is to increase the vertical integration of QLE's business in the nuclear fuel cycle.

    Currently, the Department of Energy is responsible for managing all nuclear waste created by commercial and public reactors and pays a processing fee to current reactor owners to store the fuel on behalf of the Department of Energy. The total estimated liability for the Department of Energy failing to dispose of commercial spent fuel was estimated at $44.5 billion in 2024, not including funds already paid out. [2]

    It is estimated that there are currently 390,000 Metric Tons of radioactive waste globally. [1] Roughly 3% of the total nuclear waste volume is considered High-Level Waste (HLW). HLW, although a small amount of total volume contains 95% of the radioactivity in nuclear waste. [1] Using the technology acquired from One30Seven we believe QLE will be able to develop proprietary nuclear waste decontamination solutions called Creber Units that accelerate the beta decay of this HLW and rapidly convert these long half-life isotopes into stable isotopes. The reduction of HLW reduces radioactive impact on the environment and reduces the liability of storing nuclear waste. The removal of HLW also allows for other non-HLW isotopes to be utilized for recycling and reprocessing in nuclear reactors.

    The Creber Unit solutions come in four planned sizes (Micro, Mini, Midi, and Maxi sizes) and are designed to allow for a modular approach and projected appropriate capital spending commitments and shorter timelines to revenue generation. The Creber Unit solutions allow for a mobile solution as well facilitating emergency response to nuclear waste situations.

    QLE's first targeted nuclear waste isotope for the Creber unit will be Cesium-137, which decays into stable Barium-137. The use of high-purity Barium-137 is emerging as a critical enabler of ion-trap quantum computing, one of the leading approaches to building large-scale quantum machines.

    Processing Nuclear Waste is considered to be a highly regulated process and will require a regulatory review in any country in which QLE operates to begin testing its technology. This includes working with the Nuclear Regulatory Commission (NRC), Department of Energy (DOE), Nuclear Waste Services (NWS), and other global regulators.

    Commenting on the Combination, Ryno Pretorius, CEO of Quantum Leap Energy, said:

    "This acquisition represents a transformative effort to tackle the global challenge of nuclear waste, harnessing the expertise of Brian Creber and his team to develop the Creber Unit solutions for water-soluble nuclear waste processing over the next eighteen months. This initiative promises to reduce the environmental burden of the vast quantities of radioactive waste worldwide, particularly high-level waste, by advancing solutions that could stabilize hazardous isotopes, thereby safeguarding ecosystems and public health for generations to come. Through collaboration with regulatory bodies and the application of innovative technology, this partnership aims to alleviate the economic and ecological pressures faced by entities like the U.S. Department of Energy, fostering a sustainable future on a global scale."

    Transaction Overview

    Effective October 21, 2025, Quantum Leap Energy LLC (QLE) acquired substantially all assets of One30Seven Inc., a Canadian company specializing in decontamination solutions for radioactive waste from nuclear power plants, radiopharmaceuticals, and military sources. The assets include intellectual property assets, such as an international patent application and its related rights for a system and method to treat radioactively contaminated water. This acquisition is intended to advance the development of Creber Micro, Mini, Midi, and Maxi Units and allow QLE to offer Nuclear Waste processing solutions.

    The upfront purchase price for the assets is comprised of a cash payment of $150,000 and 266,113 shares of ASPI common stock (determined by dividing $2,850,000 by a 30-day volume-weighted average price (VWAP) of ASPI common stock). Under the terms of the purchase agreement, One 30 Seven has the opportunity to earn additional consideration as follows: (i) upon the completion of a validated and operational Creber Mini Unit, an amount equal to $6,000,000, which is potentially payable in cash, shares of ASPI's common stock or shares of QLE's common equity; and (ii) upon the completion of a validated and operational Creber Midi Unit or Maxi Unit, an amount equal to $11,000,000, which is potentially payable in cash, shares of ASPI's common stock or shares of QLE's common equity. 

    QLE also entered into a consulting agreement with B-Con Engineering Inc., led by inventor Brian Creber, to develop and validate the functional operation of a Creber Mini Unit at an estimated cost of $4.5 million over 18 months, followed by either a Midi or Maxi Unit at approximately $12.5-13 million over another 18 months. QLE has agreed to fund the project through quarterly advances, with acceptance testing and monthly reporting to ensure milestones are met.

    QLE also entered into a royalty agreement with One30Seven pursuant to which QLE agreed to pay a 6.0% royalty on net revenues from product sales or licensing for 15 years per product, starting from the first commercial sale. The royalty agreement will terminate if the commercialization of a Creber Unit is not achieved by the fourth anniversary of closing.

    [1] https://world-nuclear.org/information-library/nuclear-fuel-cycle/nuclear-waste/radioactive-waste-management

    [2] https://www.ans.org/news/article-6587/us-spent-fuel-liability-jumps-to-445-billion/

    Forward Looking Statements

    This press release contains "forward-looking statements" within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are based only on our current beliefs, expectations, and assumptions regarding the future of our business, future plans and strategies, projections, anticipated events and trends, the economy, and other future conditions. Forward-looking statements can be identified by words such as "goal", "target", "believes," "plans," "anticipates," "expects," "aims", "intends", "estimates," "projects," "will," "may," "might," "seeks", "sees", "should," "would," "expect," "positioned," "strategy," and words of a similar nature. Examples of forward-looking statements include, among others but are not limited to, statements relating to the completion of the development of nuclear fuel processing solutions in the anticipated timeframe or at all, the integration of QLE's and One 30 Seven's businesses and the ability to recognize the anticipated synergies and benefits of the transactions, the anticipated market demand for QLE's future nuclear fuel processing solutions, and the company's discussions with nuclear regulators, and statements we make regarding expected operating results, such as future revenues and prospects from the potential commercialization of isotopes, future performance under contracts, and our strategies for product development, engaging with potential customers, market position, and financial results. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks, and changes in circumstances that are difficult to predict, many of which are outside our control. Our actual results, financial condition, and events may differ materially from those indicated in the forward-looking statements based upon a number of factors. Forward-looking statements are not a guarantee of future performance or developments. You are strongly cautioned that reliance on any forward-looking statements involves known and unknown risks and uncertainties. Therefore, you should not rely on any of these forward-looking statements. There are many important factors that could cause our actual results and financial condition to differ materially from those indicated in the forward-looking statements, including, but not limited to, risks related to the factors disclosed in Part I, Item 1A. "Risk Factors" of the company's Annual Report on Form 10-K for the fiscal year ended December 31, 2024 and any amendments thereto and in the company's subsequent reports and filings with the U.S. Securities and Exchange Commission. Any forward-looking statement made by us in this press release is based only on information currently available to us and speaks only as of the date on which it is made. We undertake no obligation to publicly update any forward-looking statement, whether as a result of new information, future developments or otherwise. No information in this press release should be interpreted as an indication of future success, revenues, results of operation, or stock price. All forward-looking statements herein are qualified by reference to the cautionary statements set forth herein and should not be relied upon.

    Contacts

    Jason Assad – Investor relations

    Email: [email protected]

    Telephone: 561-709-3043



    Primary Logo

    Get the next $ASPI alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ASPI

    DatePrice TargetRatingAnalyst
    10/4/2024$4.50Buy
    Canaccord Genuity
    12/5/2023$3.25Buy
    H.C. Wainwright
    More analyst ratings

    $ASPI
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Interim CEO and COO Ainscow Robert sold $305,978 worth of shares (22,500 units at $13.60), decreasing direct ownership by 1% to 1,647,193 units (SEC Form 4)

    4 - ASP Isotopes Inc. (0001921865) (Issuer)

    10/16/25 9:16:59 PM ET
    $ASPI
    Major Chemicals
    Industrials

    Director Wider Todd exercised 96,000 shares at a strike of $2.00, covered exercise/tax liability with 21,892 shares and sold $648,823 worth of shares (74,108 units at $8.76) (SEC Form 4)

    4 - ASP Isotopes Inc. (0001921865) (Issuer)

    10/3/25 8:25:54 PM ET
    $ASPI
    Major Chemicals
    Industrials

    Director Gorley Michael sold $624,237 worth of shares (64,000 units at $9.75), decreasing direct ownership by 44% to 81,360 units (SEC Form 4)

    4 - ASP Isotopes Inc. (0001921865) (Issuer)

    10/2/25 8:29:05 PM ET
    $ASPI
    Major Chemicals
    Industrials

    $ASPI
    Leadership Updates

    Live Leadership Updates

    View All

    Nuclear Power Industry Veteran Ralph Hunter Joins Board of Directors of ASP Isotopes Inc. and Board of Managers of Quantum Leap Energy LLC

    WASHINGTON, Sept. 08, 2025 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. NASDAQ: ASPI ("ASP Isotopes" or the "Company"), an advanced materials company dedicated to the development of technology and processes for the production of isotopes for use in multiple industries, today announced the appointment of Ralph L. Hunter, Jr. to the board of directors of ASP Isotopes and the board of managers of Quantum Leap Energy LLC. Ralph L. Hunter, Jr. has over thirty years' experience in the nuclear power industry in leadership roles spanning strategy, operations, and innovation, and he brings expertise in nuclear technology development and commercialization, energy systems, and market development. Mr. Hun

    9/8/25 8:00:00 AM ET
    $ASPI
    Major Chemicals
    Industrials

    ASP Isotopes Issues Letter to Shareholders

    WASHINGTON, Sept. 02, 2025 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. (NASDAQ:ASPI) ("ASP Isotopes" or the "Company"), an advanced materials company dedicated to the development of technology and processes for the production of isotopes for use in multiple industries, today released the following letter to shareholders from its Chairman and CEO, Paul Mann. Dear Fellow Shareholder, The past few months have been exciting and highly rewarding as the Company has brought three isotope enrichment facilities into operation. I am delighted to report that the Company has now shipped the first samples of both Ytterbium-176 and Silicon-28 to customers, a major milestone for the Company that should allo

    9/2/25 7:30:00 AM ET
    $ASPI
    Major Chemicals
    Industrials

    ASP Isotopes Inc. Announces Expected Commencement of Dual Listing on Johannesburg Stock Exchange

    WASHINGTON, Aug. 08, 2025 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. NASDAQ: ASPI ("ASP Isotopes" or the "Company"), an advanced materials company dedicated to the development of technology and processes for the production of isotopes for use in multiple industries, today provided an update on its application to list on the Johannesburg Stock Exchange ("JSE"). The JSE has approved the listing of the Company's common stock on the Main Board of the JSE under the abbreviated name "ASPI", share code "ISO" and international securities identification number US00218A1051, with commencement of trading expected on Wednesday, August 27, 2025. The Company will retain its primary listing on the Nasdaq Cap

    8/8/25 9:00:00 AM ET
    $ASPI
    Major Chemicals
    Industrials

    $ASPI
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Quantum Leap Energy LLC Completes the Acquisition of One 30 Seven Inc. Assets to Advance Solutions for the Processing of Water-Soluble Nuclear Waste

    Quantum Leap Energy LLC plans to utilize technology acquired from One 30 Seven to develop Creber Units to process water-soluble nuclear waste by accelerating beta decay of radioactive waste, such as Cesium-137 and Strontium-90.There are currently 390,000 Metric Tons of radioactive waste globally, of which over 90,000 Metric Tons sit in the United States. [1]The total estimated liability for the Department of Energy failing to dispose of commercial spent fuel was estimated at $44.5 billion in 2024, not including funds already paid out. [2]After this acquisition, Quantum Leap Energy intends to operate in several critical segments of the nuclear fuel cycle, including Conversion, Deconversion, E

    10/23/25 8:00:00 AM ET
    $ASPI
    Major Chemicals
    Industrials

    ASP Isotopes Inc. Announces Pricing of Public Offering of Common Stock

    WASHINGTON, Oct. 15, 2025 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. NASDAQ: ASPI ("ASP Isotopes" or the "Company"), an advanced materials company dedicated to the development of technology and processes for the production of isotopes for use in multiple industries, today announced the pricing of an underwritten public offering of 17,167,380 shares of its common stock for total gross proceeds of approximately $210.3 million, before deducting underwriting discounts and commissions and estimated offering expenses payable by the Company. The offering is expected to close on October 16, 2025, subject to satisfaction of customary closing conditions. All of the shares of common stock in the offering

    10/15/25 7:00:00 AM ET
    $ASPI
    Major Chemicals
    Industrials

    ASP Isotopes Inc. Announces Proposed Public Offering of Common Stock

    WASHINGTON, Oct. 14, 2025 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. NASDAQ: ASPI ("ASP Isotopes" or the "Company"), an advanced materials company dedicated to the development of technology and processes for the production of isotopes for use in multiple industries, today announced that it is commencing an underwritten public offering of shares of its common stock. The offering is subject to market conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering. Cantor and Lucid Capital Markets are acting as joint book-running managers for the offering. The offering is being made pursuant to a shelf registration

    10/14/25 4:18:47 PM ET
    $ASPI
    Major Chemicals
    Industrials

    $ASPI
    SEC Filings

    View All

    ASP Isotopes Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

    8-K - ASP Isotopes Inc. (0001921865) (Filer)

    10/23/25 5:06:13 PM ET
    $ASPI
    Major Chemicals
    Industrials

    ASP Isotopes Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits

    8-K - ASP Isotopes Inc. (0001921865) (Filer)

    10/16/25 6:16:16 AM ET
    $ASPI
    Major Chemicals
    Industrials

    SEC Form 424B5 filed by ASP Isotopes Inc.

    424B5 - ASP Isotopes Inc. (0001921865) (Filer)

    10/16/25 6:11:48 AM ET
    $ASPI
    Major Chemicals
    Industrials

    $ASPI
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Canaccord Genuity initiated coverage on ASP Isotopes with a new price target

    Canaccord Genuity initiated coverage of ASP Isotopes with a rating of Buy and set a new price target of $4.50

    10/4/24 7:13:36 AM ET
    $ASPI
    Major Chemicals
    Industrials

    H.C. Wainwright initiated coverage on ASP Isotopes with a new price target

    H.C. Wainwright initiated coverage of ASP Isotopes with a rating of Buy and set a new price target of $3.25

    12/5/23 7:36:42 AM ET
    $ASPI
    Major Chemicals
    Industrials

    $ASPI
    Financials

    Live finance-specific insights

    View All

    ASP Isotopes Inc. Hosts South African Investors in Advance of Secondary Listing on the Johannesburg Stock Exchange (JSE) and Provides Updates on its Isotope Production Plants

    - ASP Isotopes will host an investor access event on Tuesday, August 26, 2025 at its Pretoria facilities for approximately 30 South African investors. - ASP Isotopes expects to have a secondary listing on the Johannesburg Stock Exchange (JSE) and its common stock is expected to commence trading on the JSE on Wednesday, August 27, 2025. - ASP Isotopes has shipped its first samples of enriched Silicon-28 to a US-based customer and expects to complete the enrichment of the first samples of Ytterbium 176 during August 2025. - ASP Isotopes Management Team will feature on a RedChip Investor call at 4:15 pm EDT on Thursday, August 28, 2025. Ryno Pretorius, CEO of Quantum Leap Energy, and Stefano

    8/26/25 8:00:00 AM ET
    $ASPI
    Major Chemicals
    Industrials

    ASP Isotopes Inc. and IsoBio, Inc. Announce Series Seed Funding of IsoBio, Inc. to Advance Innovative Antibody-Isotope Conjugates (AICsTM) For Cancer Treatment

    - IsoBio, Inc. (IsoBio) is a U.S.-based radiotherapeutic development company focused on developing a broad pipeline of mAb-based radioisotope therapeutics, known as antibody-isotope conjugates (AICsTM), targeting both derisked and novel tumor antigens for patients in need of new cancer therapies. - IsoBio has closed its initial Series Seed financing round, raising $5 million from ASP Isotopes Inc. (ASPI). - The strategic collaboration contemplates future manufacturing opportunities for PET Labs (ASPI's nuclear medicine subsidiary). - IsoBio plans to leverage the technology and global manufacturing capabilities developed by ASPI to reduce the uncertainty of isotope supply chain/manufacturi

    7/28/25 8:31:17 AM ET
    $ASPI
    $IMNM
    Major Chemicals
    Industrials
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Mobilicom and ASP Isotopes Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

    ORLANDO, FL / ACCESSWIRE / September 13, 2024 / RedChip Companies will air interviews with Mobilicom Ltd. (NASDAQ:MOB) and ASP Isotopes Inc. (NASDAQ:ASPI) on the RedChip Small Stocks, Big Money™ show, a sponsored program on Bloomberg TV, this Saturday, September 14, at 7 p.m. Eastern Time (ET). Bloomberg TV is available in an estimated 73 million homes across the U.S.Access the interviews in their entirety at:Mobilicom: https://www.redchip.com/assets/access/mob_accessASP Isotopes: https://www.redchip.com/assets/access/aspi_accessOren Elkayam, Founder and CEO of Mobilicom, appears on the RedChip Small Stocks, Big Money™ show on Bloomberg TV to provide a corporate update. Mobilicom presents a

    9/13/24 9:00:00 AM ET
    $ASPI
    $BOXL
    $MOB
    Major Chemicals
    Industrials
    Other Consumer Services
    Real Estate

    $ASPI
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Operating Officer Ainscow Robert bought 19,992 shares, increasing direct ownership by 2% to 919,992 units (SEC Form 4)

    4 - ASP Isotopes Inc. (0001921865) (Issuer)

    7/15/24 10:33:49 AM ET
    $ASPI
    Major Chemicals
    Industrials

    Chief Executive Officer Mann Paul Elliot bought 39,984 shares, increasing direct ownership by 0.69% to 5,845,627 units (SEC Form 4)

    4 - ASP Isotopes Inc. (0001921865) (Issuer)

    7/15/24 10:33:33 AM ET
    $ASPI
    Major Chemicals
    Industrials

    Large owner Ak Jensen Investment Management Ltd bought $515,088 worth of shares (161,849 units at $3.18) (SEC Form 4)

    4 - ASP Isotopes Inc. (0001921865) (Issuer)

    7/10/24 5:59:47 PM ET
    $ASPI
    Major Chemicals
    Industrials

    $ASPI
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by ASP Isotopes Inc.

    SC 13G - ASP Isotopes Inc. (0001921865) (Subject)

    11/14/24 3:01:19 PM ET
    $ASPI
    Major Chemicals
    Industrials

    Amendment: SEC Form SC 13G/A filed by ASP Isotopes Inc.

    SC 13G/A - ASP Isotopes Inc. (0001921865) (Subject)

    11/7/24 4:15:14 PM ET
    $ASPI
    Major Chemicals
    Industrials

    SEC Form SC 13G filed by ASP Isotopes Inc.

    SC 13G - ASP Isotopes Inc. (0001921865) (Subject)

    11/3/23 4:15:20 PM ET
    $ASPI
    Major Chemicals
    Industrials